METASTATIC
Clinical trials for METASTATIC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC trials appear
Sign up with your email to follow new studies for METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive ray of hope for deadly eye cancer
Disease control Recruiting nowThis is the first study in people testing a new radioactive drug called 225Ac-MTI-201 for uveal melanoma, a rare eye cancer that has spread. The main goal is to find the highest dose that is safe for patients who have already tried at least one other treatment. Researchers will g…
Matched conditions: METASTATIC
Phase: PHASE1 • Sponsor: Modulation Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New Two-Drug attack on Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing a new combination of two existing drugs, lorlatinib and ramucirumab, for people with advanced lung cancer that has a specific genetic change called ALK. The main goals are to find the safest dose of the drug combination and to see how well it works at contro…
Matched conditions: METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat gut cancers
Disease control Recruiting nowThis study is testing a combination of three drugs (surufatinib, sintilimab, and capecitabine) for people with advanced small bowel or appendix cancer that has spread and worsened after at least one prior treatment. The main goals are to see if this combination is safe and if it …
Matched conditions: METASTATIC
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC